Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Acute Inflammation III: Local and Systemic Effects

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Determinants of Bacterial Pathogenicity and Virulence

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT).

Frontiers in pharmacology·2022

Same author

Cell-free culture supernatant of Lactobacillus curvatus Wikim38 inhibits RANKL-induced osteoclast differentiation and ameliorates bone loss in ovariectomized mice.

Letters in applied microbiology·2021

Same author

Hemodynamic effects of Vernakalant in cardio-surgical ICU-patients treated for recent-onset postoperative atrial fibrillation.

Scientific reports·2020

Same author

Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state.

Scientific reports·2019

Same author

PCSK9 decreases during experimental endotoxemia.

Journal of internal medicine·2019

Same author

Time of out-of-hospital cardiac arrest is not associated with outcome in a metropolitan area: A multicenter cohort study.

Resuscitation·2019

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Racial differences in endotoxin-induced tissue factor-triggered coagulation.

F B Mayr¹, A O Spiel, J M Leitner

¹Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Journal of Thrombosis and Haemostasis : JTH

|February 4, 2009

Summary

Africans exhibit a reduced blood clotting response compared to Caucasians, particularly in lipopolysaccharide-induced coagulation. This difference is linked to the Duffy antigen status, impacting thrombin and fibrin formation.

More Related Videos

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

Extracellular Vesicle Tissue Factor Activity Assay

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Related Experiment Videos

Last Updated: Jun 26, 2026

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

Extracellular Vesicle Tissue Factor Activity Assay

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Area of Science:

Hematology
Immunology
Genetics

Background:

Racial differences in coagulation are not well understood, with conflicting reports on bleeding risk and prothrombotic tendencies.
Preclinical data suggests a connection between the Duffy antigen (DARC) and coagulation processes.
Previous research in Duffy antigen-negative Africans informed the current study's hypothesis.

Purpose of the Study:

To investigate the hypothesis that Africans have an attenuated procoagulant response compared to Caucasians.
To examine coagulation activation in a model of lipopolysaccharide (LPS)-induced, tissue factor (TF)-triggered coagulation.
To explore the role of Duffy antigen negativity in modulating coagulation responses.

Main Methods:

A study involving 16 Duffy-negative African and 16 Duffy-positive Caucasian healthy male volunteers.
Administration of lipopolysaccharide (LPS) at 2 ng kg(-1) to induce coagulation activation.
Measurement of outcome parameters using enzyme immunoassays and real-time polymerase chain reaction (RT-PCR).

Main Results:

LPS-induced microparticle (MP)-associated TF procoagulant activity (PCA) was lower in Africans than Caucasians.
Africans demonstrated reduced in vivo thrombin formation, evidenced by lower levels of thrombin-antithrombin (TAT) complexes and prothrombin fragments (F1+2).
Decreased fibrin formation was observed in Africans, indicated by lower D-dimer levels compared to Caucasians.

Conclusions:

Duffy-negative individuals of African descent show a significantly reduced procoagulant response.
This reduced response was observed in a model of LPS-induced, TF-triggered coagulation activation.
The findings suggest a differential coagulation profile between Duffy-negative Africans and Duffy-positive Caucasians.